Discovering dominant tumor immune archetypes in a pan-cancer censusAlexis J. Combes, Sima P. Porten, Peter Yan et al.|Cell|2021Cited by 172
GENO-25HYPERMUTATION AND MALIGNANT PROGRESSION IN AN EXPANDED COHORT OF TEMOZOLOMIDE-TREATED LOW-GRADE GLIOMA PATIENTSTali Mazor, J Costello, Brett Johnson et al.|Neuro-Oncology|2015Cited by 2